Core Scientific, Inc./tx (CORZZ)

Every figure this model derived for CORZZ, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,477,985,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,769,735,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,443,644,000 AssetsCurrent 2026-06-30
current liabilities 2,737,794,000 LiabilitiesCurrent 2026-06-30
equity -2,419,356,000 StockholdersEquity 2026-06-30
interest expense 19,661,000 InterestPaidNet 2026-06-30
ocf 520,240,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 440,311,000 Revenues 2026-06-30
sbc 93,882,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CORZZ on one particular measure came for.

RatioValue
cash operating margin-91.91
current ratio1.0
current ratio reported0.89
deferred revenue growth-43.04
dilution pct24.35
fcf margin-217.52
growth cv2.13
interest cover-28.54
operating margin-127.45
owner earnings margin-238.84
revenue growth26.37
revenue growth per share1.63
rpo growth-38.69
rule of 40-101.08
sbc pct revenue21.32

What to be careful about

What this model itself distrusts about CORZZ's figures. Written by the derivation as it ran, not added afterwards.